Immunocore is a pioneering, commercial-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and auto-immune disease. Reporting to Chief Commercial Officer and responsible for the commercial organization in Europe.General Manager for Immunocore (Switzerland) GmbH.

Reporting to the VP Oncology, region Europe and Canada head Oncology. Member of the Europe and Canada Core Leadership/management team. Supporting the countries with upcoming launches in Haematology-Oncology and translating global strategy in the region, assuring launch readiness, ambitious long range plan and setting up right level of resources. Establish AstraZeneca as a partner in Haematology-Oncology. Building the European haematology franchise for our launch in chronic lymphocytic leukemia (CLL). Preparation of our upcoming launches in immuno-oncology (IO) and TDR in lung cancer (NSCLC and SCLC) and HCC or liver cancer. Management and maximization of our existing indications in lung cancer.

Business Unit Head German Affiliate. Member of German Management Committee. Reporting to the Vice President General Manager of Germany. Leading sales and marketing team of 50 people. 10 direct reports. P&L responsibility. Alliance management with UCB. Therapeutic area : Bone and Inflammation and new product development.

2 direct reports, crossfunctional brand team lead eu product team responsible for 28 countries, final responsible for the regional product strategy, responsible for budget and long range plan, life cycle management contact for the region, therapeutic area : Haematology, launch brand

Launch of hematology brand responsible for 28 European countries, International marketing launch brand, campaign development, congresses, multichannel, value based healthcare, patient support, commercial innovation, competitive development, integration of Onyx within Amgen in Europe, therapeutic area : haematology

Direct reports : national team of sales reps in haematology, creating and piloting the model of a haematology business unit into the onco haematology devisionSales and marketing responsibilities for that haematology unit, therapeutic area : oncology-haematology

Two launches in oncology and haematology (1 orphan drug), responsible for campaign management, congresses, national brand plan, budgets and long range plan, market research, insights and analysis, scientific expert and key opinion leader contact. Two launches with highest sales per capita in Europe

1 mature brand and 1 assisted launch in oncology, responsible for supportive care drug in cancer and its campaign management. Market research, marketing projects

Consultancy

1 in line brand and 1 launch in haematology / oncology, responsible for medical communication and information, interaction with scientific experts and doctors through medinfo questions, approval of promotional materials, close collaboration with product manager and sales representatives, medical support to shape the strategy, lead of a phase IV clinical trial in haematology

Hospital sales rep and key account management for urologists, anesthesiologists, intensive care physicians, gastro enterologists, gynaecologists and hospital pharmacists, responsible to launch anesthesiology portfolio and standard solutions in a high competitive and price sensitive market, responsible for the entry to market of Fresenius medical devicesSector : All hospitals in North Region, Flanders